Skip to content

Effect of perioperative multimodal analgesia based on enrikefon on postoperative fatigue syndrome in patients undergoing thoracoscopic pneumonectomy: a randomized controlled trial

Effect of perioperative multimodal analgesia based on enrikefon on postoperative fatigue syndrome in patients undergoing thoracoscopic pneumonectomy: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109513
Enrollment
Unknown
Registered
2025-09-19
Start date
2025-09-22
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung surgery

Interventions

enrikefon group:Patients received 1ug/kg enrikefon in 20mL 0.9% normal saline infusion 30min before the start of surgery. The PCIA pump was connected at the end of the operation, and the formula was s
control group:20mL of 0.9% saline was injected intravenously 30min before the start of the procedure. At the end of operation, PCIA pump was connected with the formula of sufentanil 3 µg/kg and flurb

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who intend to electively undergo thoracoscopic partial lung resection under general anesthesia; 2. Age 18-65 years, gender is not limited; 3. American Society of Anesthesiologists (ASA) grade I-III; 4. Know, agree to participate in the trial and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.patients with a history of allergy to opioids or local anesthetics, or allergy to intraoperative anesthetics specified in the protocol; 2.patients with preoperative chronic pain or long-term use of analgesics; 3.severe heart disease (NYHA class III or IV), liver disease (Child-Pugh score 10-15), kidney disease (renal replacement therapy), hematopoietic system disease (leukemia); 4.patients with preoperative mental disease, language disorder, or other factors leading to communication difficulties and unable to complete the scale assessment; 5.refused to participate or participated in other clinical research in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Postoperative fatigue syndrome;

Secondary

MeasureTime frame
Postoperative quality of recovery;Pain score;Opioid-related adverse reactions;Postoperative opioid use;Postoperative sleep quality;

Countries

China

Contacts

Public ContactChen Lijian

The First Affiliated Hospital of Anhui Medical University

chenlijian77@126.com+86 139 6669 9467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026